trial · primary record
AM-928
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 38 |
| Primary completion | 2028-04 |
| Primary endpoint | The maximum tolerated dose (MTD) |
| Registry ID | NCT05687682 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.669Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05687682
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.